Publications by authors named "Ann Haig"

Claim this Profile
L
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.
Florence E Roufosse, Jean-Emmanuel Kahn, Gerald J Gleich, Lawrence B Schwartz, Anish D Singh, Ann E Haig

J Allergy Clin Immunol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of patients with the hypereosinophilic syndrome with mepolizumab.
Marc E Rothenberg, Amy D Klion, Florence E Roufosse, Jean Emmanuel Kahn, Peter F Weller, Ann E Haig

N Engl J Med· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo response in two long-term randomized psoriasis studies that were negative for rosiglitazone.
Charles N Ellis, Jonathan N Barker, Ann E Haig, Christine A Parker, Susan Daly

Am J Clin Dermatol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open label study to establish dosing recommendations for nabumetone in juvenile rheumatoid arthritis.
Steve Goodman, Paul Howard, Ann Haig, Susan Flavin, Brian Macdonald

J Rheumatol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors.
Robert Palmer, Robert Weiss, Randall M Zusman, Ann Haig, Susan Flavin

Am J Hypertens· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis